Skip to content

Clinical trials

Completed Leukemia, Myeloid, Acute trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Status: Completed Country / region: Japan Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20091
20101
20113
20123
20132
20144
20154
20166
20176
20185
20191
20203
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie6
Astellas Pharma Global Development, Inc.5
Otsuka Pharmaceutical Co., Ltd.5
Daiichi Sankyo Co., Ltd.4
Novartis Pharmaceuticals4
Pfizer3
Astellas Pharma Inc2
Astex Pharmaceuticals, Inc.2
AstraZeneca2
Boehringer Ingelheim2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute43
Myelodysplastic Syndromes8
Neoplasms6
Hematologic Neoplasms3
Leukemia3
Leukemia, Myelomonocytic, Chronic3
Lymphoma, Non-Hodgkin3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive2
Multiple Myeloma2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.